)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Sanofi India
Sanofi India (500674) investor relations material
Sanofi India Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 Apr, 2026
Executive summary
Unaudited financial results for the quarter ended March 31, 2026, were approved by the Board of Directors.
Insulin portfolio achieved double-digit growth both year-over-year and sequentially, marking strong performance in the domestic market.
Strategic partnerships in Cardiovascular, Oral anti-diabetes, and CNS segments have strengthened the business foundation.
Export sales are stabilizing despite ongoing geopolitical challenges.
Operational excellence and efficiency improvements continue through targeted market initiatives.
Significant events and developments
Tenure of two Independent Directors, Mr. Aditya Narayan and Mrs. Usha Thorat, completed as of April 29, 2026.
Mr. Rahul Bhatnagar appointed as Chairman of the Board effective April 30, 2026.
Board reconstituted key committees, including Audit, Nomination and Remuneration, Stakeholders Relationship, Risk Management, and CSR Committees, with new leadership and memberships effective April 30, 2026.
Segment performance
Insulin portfolio delivered 14% sequential growth and 19% year-over-year growth, maintaining leadership in the diabetes injectable segment.
Strategic partnerships in other therapeutic areas are expected to catalyze further growth and market penetration.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sanofi India
- Net profit rose to ₹3,267m; diabetes led growth; total dividend proposed at ₹123/share.500674
Q4 20258 Apr 2026 - Margin and profit growth driven by diabetes focus, digital tools, and operational efficiency.500674Q3 20253 Feb 2026
- Sequential revenue and profit declined, with leadership changes and a new OAD distribution deal.500674Q2 202531 Jul 2025
- Q3 2024 saw 8% sales growth and a successful demerger, with strong diabetes portfolio gains.500674Q3 202413 Jun 2025
- Demerger, supply issues, and restructuring shaped Q2, but diabetes brands led market growth.500674Q2 202413 Jun 2025
- Q1-2025 saw 4% sales growth and 27% higher operating profit, with continued focus on innovation.500674Q1 20256 Jun 2025
- Q4-2024 net sales rose 8% and a ₹117/share dividend was recommended for FY2024.500674Q4 20246 Jun 2025
Next Sanofi India earnings date
Q2 202624 Jul, 2026
Sanofi India
Next Sanofi India earnings date
Q2 202624 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage